Pharmacology, Toxicology and Pharmaceutical Science
Ethanol
100%
Liver Injury
49%
Liver Disease
31%
Mouse
27%
Trimethylglycine
26%
Alcohol Liver Disease
25%
Disease
19%
HIV
19%
Hepatitis C Virus
19%
Proteasome
18%
Nonalcoholic Fatty Liver
16%
Hepatitis B Virus
16%
Infection
15%
Steatosis
15%
Fatty Liver
15%
Liver Cirrhosis
14%
Interferon
14%
Hepatotoxicity
13%
Liver Fibrosis
12%
Fibrosis
11%
CYP2E1
10%
Hepatitis B
9%
Cytokine
8%
Liver Cell Carcinoma
8%
Guanidinoacetic Acid
8%
S-Adenosyl Methionine
8%
Hepatitis A
8%
S Adenosylhomocysteine
7%
Hepatitis C
7%
End Stage Liver Disease
7%
Antivirus Agent
7%
3 Deazaadenosine
6%
Human Immunodeficiency Virus Infection
6%
Elimination
5%
Inflammation
5%
Transgenic Mouse
5%
Virus Hepatitis
5%
Methyl Group
5%
Tumor Necrosis Factor
5%
Immunology and Microbiology
Human Immunodeficiency Virus
45%
Proteasome
43%
Liver Cell
29%
Hepatitis C Virus
28%
Alcohol Metabolism
26%
Hepatic Stellate Cell
25%
Macrophage
25%
Hepatitis B
22%
Interferon Gamma
19%
Oxidative Stress
19%
Antigen Presentation
19%
Hepatitis C
14%
Methylation
13%
Hepatitis Virus
13%
Lipid Storage
11%
interferon
11%
Hepatitis B Virus
11%
Innate Immune System
10%
Cell Activation
10%
Human Immunodeficiency Virus Infection
9%
Hepatitis A
9%
Dynamics
8%
Lysosome
8%
Mouse
8%
Human Immunodeficiency Virus 1
8%
Lipid Liver Level
8%
Protein Binding
8%
Histamine
8%
Adipose Tissue
8%
Enzyme Activity
8%
Major Histocompatibility Complex
8%
Surface Property
8%
Cell Death
7%
T Cell
7%
Apoptosis
7%
Cytokine Signaling
6%
Immune Response
6%
Secretion (Process)
6%
Cell Proliferation
6%
MHC Class I
6%
Viral Disease
5%
Inflammasome
5%
Immunocompetent Cell
5%
Cell Function
5%
Splenocyte
5%
Monocyte
5%
Supernatant
5%
Keyphrases
Hepatocytes
30%
Alcohol
29%
Ethanol
24%
Alcoholic Liver Disease
23%
Liver
18%
Apoptotic Bodies
16%
Hepatitis C Virus
16%
Hepatic Stellate Cells
14%
Acetaldehyde
13%
Steatosis
12%
Liver Fibrosis
11%
Liver Injury
10%
Hepatic Stellate Cell Activation
8%
Liver Disease
8%
Early Growth Response Protein 1 (EGR1)
8%
Non-alcoholic Fatty Liver Disease (NAFLD)
8%
Hepatitis C
8%
Alcohol-induced
8%
Disease Pathogenesis
7%
Cirrhosis
7%
Non-parenchymal Cells
7%
Proteasome Activity
7%
Endoplasmic Reticulum Stress (ER stress)
6%
Profibrotic
6%
HCV Infection
6%
Alcohol Exposure
6%
Excessive Drinking
6%
Liver Damage
5%
Alcoholic Liver Injury
5%
Guanidinoacetate Methyltransferase
5%
Innate Immunity
5%
Alcoholism
5%
MHC Class I
5%
T Cells
5%
Immunoproteasome
5%
Macrophages
5%
Human Hepatocytes
5%
Fibrosis Development
5%
Hepatitis B
5%
